Of note, the use of GM-CSF and TAM (tumor associated macrophages) inhibitors, like CSF-1R, have shown promising results in blocking the crosstalk between macrophages and tumor cells (Liu et al., 2016; Li et al., 2020). The gene discussed is CSF1R; the disease is neoplasm.